1SG5

Solution structure of Yaeo, a Rho-specific inhibitor of transcription termination

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D_13C-separated_NOESY	2mM YaeO,U-15N, 13C, 150mM phophate buffer, 2.0mM DTT; 0.1 mM NaN3, 90% H2O, 10% D2O	90% H2O/10% D2O		7.0	ambient	303
2	3D_15N-separated_NOESY	2mM YaeO,U-15N, 150mM phophate buffer, 2.0mM DTT; 0.1 mM NaN3, 90% H2O, 10% D2O	90% H2O/10% D2O		7.0	ambient	303
3	2D NOESY	2mM YaeO, 150mM phophate buffer, 2.0mM DTT; 0.1 mM NaN3,90% H2O, 10% D2O	90% H2O/10% D2O		7.0	ambient	303
4	2D NOESY	2mM YaeO, 150mM phophate buffer, 2.0mM DTT; 0.1 mM NaN3	100% D20		7.0	ambient	303

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
simulated annealing		XwinNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with favorable non-bond energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Additional NMR Experimental Information
Details	Structure determined using standar triple resonance and homonuclear techniques

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	XwinNMR	2.5	Bruker Biospin
2	data analysis	XEASY	1.3.13	Bartels
3	data analysis	ARIA	1.1	Nilges
4	refinement	CNS	1.1	Brunger
5	collection	XwinNMR	2.1	Bruker Biospin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.